GB0613927D0 - Pharmaceutically acceptable salt and polymorphic forms - Google Patents

Pharmaceutically acceptable salt and polymorphic forms

Info

Publication number
GB0613927D0
GB0613927D0 GBGB0613927.3A GB0613927A GB0613927D0 GB 0613927 D0 GB0613927 D0 GB 0613927D0 GB 0613927 A GB0613927 A GB 0613927A GB 0613927 D0 GB0613927 D0 GB 0613927D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutically acceptable
acceptable salt
polymorphic forms
polymorphic
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0613927.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Original Assignee
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo, Pliva Istrazivanje i Razvoj doo filed Critical Pliva Hrvatska doo
Priority to GBGB0613927.3A priority Critical patent/GB0613927D0/en
Publication of GB0613927D0 publication Critical patent/GB0613927D0/en
Priority to DE202007019054U priority patent/DE202007019054U1/en
Priority to DE102007032613A priority patent/DE102007032613A1/en
Priority to EP07848377A priority patent/EP2069360A2/en
Priority to PCT/GB2007/002653 priority patent/WO2008008024A2/en
Priority to EP07769012A priority patent/EP2057170A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0613927.3A 2006-07-13 2006-07-13 Pharmaceutically acceptable salt and polymorphic forms Ceased GB0613927D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0613927.3A GB0613927D0 (en) 2006-07-13 2006-07-13 Pharmaceutically acceptable salt and polymorphic forms
DE202007019054U DE202007019054U1 (en) 2006-07-13 2007-07-12 Spirapril hydrochloride and polymorphic forms thereof
DE102007032613A DE102007032613A1 (en) 2006-07-13 2007-07-12 Spirapril hydrochloride and polymorphic forms thereof
EP07848377A EP2069360A2 (en) 2006-07-13 2007-07-13 Polymorphic forms of spirapril hydrochloride
PCT/GB2007/002653 WO2008008024A2 (en) 2006-07-13 2007-07-13 Polymorphic forms of spirapril hydrochloride
EP07769012A EP2057170A2 (en) 2006-07-13 2007-07-13 Polymorphic forms of spirapril hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0613927.3A GB0613927D0 (en) 2006-07-13 2006-07-13 Pharmaceutically acceptable salt and polymorphic forms

Publications (1)

Publication Number Publication Date
GB0613927D0 true GB0613927D0 (en) 2006-08-23

Family

ID=36955585

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0613927.3A Ceased GB0613927D0 (en) 2006-07-13 2006-07-13 Pharmaceutically acceptable salt and polymorphic forms

Country Status (4)

Country Link
EP (1) EP2069360A2 (en)
DE (2) DE202007019054U1 (en)
GB (1) GB0613927D0 (en)
WO (1) WO2008008024A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4847384A (en) * 1987-03-12 1989-07-11 Sandoz Pharm. Corp. Process for the preparation of certain nitrogen-containing mono- and bicyclic ace inhibitors, and novel intermediates useful therefor
US5403593A (en) 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms

Also Published As

Publication number Publication date
WO2008008024A2 (en) 2008-01-17
DE102007032613A1 (en) 2008-01-24
EP2069360A2 (en) 2009-06-17
WO2008008024A9 (en) 2008-03-13
DE202007019054U1 (en) 2010-05-12
WO2008008024A3 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
HUS000509I2 (en) Abemaciclib or pharmaceutically acceptable salt thereof
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
IL196543A0 (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
EP1973405A4 (en) Hydroxyalkylarylamide derivatives
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
GB0606234D0 (en) Pharmaceutically acceptable salts and polymorphic forms
HK1136276A1 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2-
IL193211A0 (en) Indazole-heteroaryl derivatives
ZA200807614B (en) Buprenorphine derivatives and uses thereof
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
EP2043633A4 (en) Thiadiazolidinone derivatives
GB0600749D0 (en) Pharmaceutically acceptable co-crystalline forms
GB0613928D0 (en) Pharmaceutically acceptable salt and polymorphic forms
GB0712915D0 (en) Club alert
IL197239A0 (en) Phenyloxyaniline derivatives
EP1864986A4 (en) Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof
GB0605344D0 (en) Pharmaceutically acceptable salts and polymorphic forms
GB0620915D0 (en) Golfing aid
GB0519891D0 (en) Pharmaceutically acceptable salts and hydrates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)